SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Big Sponsors > Novartis

ICIG completes acquisition of Sandoz site

04-Apr-2016 - International Chemical Investors Group (ICIG) has completed its acquisition of Sandoz Industrial Products GmbH from Novartis Group.

Novartis joint venture helps virtual trial CRO to $6.5m fundraising round

26-Oct-2015 - Science 37 has raised $6.5m (€5.7m) from Lux Capital and dRx Capital, the fund set up by Novartis and Qualcomm, to advance its virtual clinical trial service business.

CPhI Worldwide 2015

As it happened: CPhI Pharma Awards winners announced

14-Oct-2015 -   [View the story "2015 CPhI Pharma Awards winners" on Storify]

Novartis extends Unilife deal for drug delivery device

29-Sep-2015 - Novartis has extended a deal with Unilife for the supply of an injectable drug delivery system for use with an early stage drug candidate.

Recipharm in talks to buy French eye drug plant from Alcon

07-Sep-2015 - Recipharm plans to buy an aseptic Blow-Fill-Seal plant from Alcon and turn it into a contract manufacturing site.

News in brief

Merck recalls 276,000 pill bottles

20-Aug-2015 - Merck & Co. has recalled two chemotherapy products because of cracked caps, including one it manufactures for Novartis’ Sandoz.

News in brief

Novartis' Mereo selects Icon as exclusive provider of development services

04-Aug-2015 - Mereo BioPharma Group, a recently-formed  specialty biopharma company, has selected CRO (contract research organization) Icon as its sole provider of clinical development services. 

Pediatric trials in EU increase as overall trials decline, Commission report says

01-Jun-2015 - The proportion of pediatric trials of all clinical trials in the EU continues to increase since the integration of a Pediatric regulation in 2007, despite a decrease in the number...

CROs look to buttress research models businesses with CRISPR/Cas tech

25-May-2015 - As the largest pharma and tech suppliers – from Novartis  to GE Healthcare  to Thermo Fisher  – begin exploring the world of CRISPR/Cas gene editing technology, contract research organizations are also looking into the new tech...

Bio-CMO sector to grow over 40% on Big Biopharma's burgeoning pipelines

24-Apr-2015 - Cheaper disposable manufacturing techs and increased demand for outsourced production will see more CMOs enter the contracting sector according to HighTech Business Decisions

Sigma-Aldrich opens doors to latest Singapore biopharma investment

22-Apr-2015 - Sigma-Aldrich has opened a cell culture Technical Center in Singapore and plans to expand further in the city-state with a cGMP distribution site.

Does Europe’s Evotec offer an outsourcing model for the future?

24-Mar-2015 - With a small pipeline of clinical candidates, as well as R&D partnerships with top Big Pharma companies paying for those partnerships, Evotec could be in a position to re-define what...

Clinical Ink merges with CentrosHealth to create new trial tech platform

20-Mar-2015 - eSource solution provider Clinical Ink is merging with CentrosHealth, a provider of mobile apps for clinical trial patient engagement and electronic patient reported outcomes (ePRO). 

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told Outsourcing-pharma.com the preclinical CRO may add scale to US...

Novartis-Qualcomm deal leads race to bring wearable tech to pharma

19-Jan-2015 - Big pharma and CROs looking to exploit wearable technology in clinical trials will need to overcome reliability and regulatory problems, says an expert.

Novartis to close Puerto Rico plant and outsource to Eli Lilly

19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.

CMO use to grow despite Big Biopharma's in-house spend, say experts

02-Dec-2014 - Third-party manufacturers anxious about Big Biopharma investments and downbeat industry reports can relax as experts concur “it’s a time of growth for biopharmaceutical outsourcing.”

Collaboration can fix ‘broken’ clinical trials model TransCelerate CEO tells CROs

18-Nov-2014 - Collaboration does not mean drugmakers have started playing nice, it’s just that the pain of shared problems has become unbearable according to TransCelerate Biopharma CEO, Dalvir Gill.

Dispatches from the Financial Times Global Pharmaceutical and Biotechnology Conference

Pipelines not tax cutting should prompt smaller pharma mergers says AstraZeneca exec

18-Nov-2014 - 2014 has seen record pharma M&A activity but top management of some of the key dealmakers – including Novartis, AstraZeneca and Shire – say size doesn’t always matter.

Sanofi wearable injectable supply deal could net Unilife over $1bn per year

12-Nov-2014 - Unilife says its 15 year-wearable injector supply deal with Sanofi is “unprecendented” and could result in over $1bn of sales annually for the delivery device maker. 

Mercks & recreation? The pharma industry and the sporting world

03-Nov-2014 - In an Outsourcing-Pharma sporting special, we reveal why GSK will not be at the Rio Olympics, why PPD has renewed its ironman triathlon sponsorship, and what became of BMS' partnership with Lance...

Novartis calls on Covance to help with Big Data

16-Oct-2014 - Covance’s collection of drug development data is set to get bigger though a collaboration with Swiss drugmaker Novartis.

Novartis calls in third-party trial reviewer after Japan SAE scandal

17-Jun-2014 - Novartis has called in a third party organization to review how it conducts clinical trials in light of the adverse event reporting scandal that broke in Japan last week.

Novartis closing UK site, but will $1m per week R&D spend benefit CROs?

27-Feb-2014 - Novartis says it will continue to spend around $1m a week on clinical trials in the UK after its R&D site closes in June.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...